Project 1

Effects of Cannabinoid agonists on PPI in patients with Schizophrenia

There is currently a great deal of interest and controversy regarding the relationship between cannabis use and schizophrenia. We are studying the effects of cannabis use on a biological marker of schizophrenia, prepulse inhibition of the startle reflex, in patients with schizophrenia and in otherwise healthy people using cannabis (Kedzior and Martin-Iverson, 2006; Kedzior et al., 2006; Kedzior and Martin-Iverson, 2007). This research is carried out at the Neurophysiology Unit of Graylands Hospital.